Pieris-AG Pieris Pharmaceuticals, Inc.

Welcome to Pieris

Pieris is developing Anticalin® product candidates to help patients suffering from cancer, severe asthma, anemia and other medical conditions with a high unmet medical need.

Partnerships

Pieris is always happy to discuss partnering opportunities around its proprietary programs and any new drug discovery partnerships where a partner wants to couple its target know-how with the differentiating features of the Anticalin drug class.

Learn more on how to partner with Pieris »

News

05/19/15

Pieris Pharmaceuticals to Present Data on Novel Anti-CD137 and HER2 Bispecific Immuno-Oncology Program at UBS Global Healthcare Conference

Read More »
Pieris Pharmaceuticals, Inc. Investor Presentation

Investor Presentation

Pieris Pharmaceuticals, Inc.

Fact Sheet

Stock Info

OTCQB
PIRS
Change
Volume
Market Cap
Email Alerts